GUANGJI PHARMA.(SZ:000952)2022-12-05 05:58Group 1: Investor Relations Activities - A total of 33 investors and industry researchers participated in the investor communication meeting of Guangji Pharmaceutical [1] - The meeting was held on January 19, 2017, from 15:00 to 17:00 at Marco Polo Hotel, Shenzhen [3] Group 2: Company Strategy and Development - Guangji Pharmaceutical aims to purchase office space in Wuhan to overcome regional limitations and attract high-end management and technical talent [2] - The new office location in Wuhan's East Lake New Technology Development Zone is strategically beneficial due to the concentration of technology, talent, and policy resources [4] - The company plans to pursue external development as a primary direction for future growth, in line with provincial state-owned asset management policies [4] Group 3: Shareholder Composition and Future Plans - The major shareholder of Guangji Pharmaceutical is the Provincial Long-term Investment Group, with other shareholders remaining relatively stable [4] - The company encourages investors to adopt a strategic investor perspective and align with its strategic planning and development [4]